Form 8-K - Current report:
SEC Accession No. 0001193125-26-271117
Filing Date
2026-06-15
Accepted
2026-06-15 16:15:51
Documents
14
Period of Report
2026-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d65233d8k.htm   iXBRL 8-K 28188
2 EX-99.1 d65233dex991.htm EX-99.1 18268
3 EX-99.2 d65233dex992.htm EX-99.2 10298
4 EX-99.3 d65233dex993.htm EX-99.3 10286
  Complete submission text file 0001193125-26-271117.txt   198193

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adpt-20260615.xsd EX-101.SCH 3202
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20260615_lab.xml EX-101.LAB 17993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20260615_pre.xml EX-101.PRE 11276
18 EXTRACTED XBRL INSTANCE DOCUMENT d65233d8k_htm.xml XML 3686
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 261091025
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)